Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Catherine Labbé, pneumologue spécialisée en oncologie pulmonaire à l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), au sujet de tout ce qu'il faut savoir sur le dépistage du cancer du poumon : qui est admissible, quels sont les critères et pourquoi est-il important de se faire dépister si vous présentez un risque élevé ?

In our new series called Perspectives on Lung Cancer, Dr. Paul Wheatley-Price sits down with two guests, both with a depth of experience in ALK+ lung cancer, which represents about 4-8% of all lung cancer cases in Canada. Dr. Cheryl Ho, medical oncologist at BC Cancer, provides her perspective as a physician treating these types of cancers in her daily practice, while Katie Hulan shares her journey as a patient diagnosed with ALK+ lung cancer in 2021, navigating the healthcare system, and her path to launching ALK Positive Canada to advocate for better awareness of this subtype of lung cancer.

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec le Dr Kevin Jao, coprésident du comité médical consultatif de Cancer pulmonaire Canada et hémato-oncologue à l'Hôpital du Sacré-Cœur-de-Montréal. Ils présentent Cancer pulmonaire Canada, tout le soutien et les ressources disponibles pour les Canadiens touchés par le cancer du poumon, et mettent particulièrement l'accent sur le Mois de la sensibilisation au cancer du poumon.

In this episode, Dr. Paul Wheatley-Price is back for our annual recap of the IASLC 2025 World Conference on Lung Cancer (WCLC), which took place in Barcelona, Spain in early September. He is joined by two special guests, Dr. Barbara Melosky, Professor of Medicine at UBC and Medical Oncologist at BC Cancer, and Dr. Peter Ellis, Professor of Oncology at McMaster University and Medical Oncologist at Juravinski Cancer Center. They chat about all the updates for treatments like osimertinib for EGFR+ lung cancer, immunotherapy for small-cell lung cancer, and promising new treatments like for HER2 and ADCs coming down the pipeline.

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec Lise Boilard, qui a reçu un diagnostic de cancer du poumon en 2017 à l'âge de 44 ans, et sa médecin traitante, la Dre Myriam Bouchard, radio-oncologue au Centre hospitalier de l'université de Sherbrooke. Lise partage son parcours inspirant face au cancer du poumon, la relation unique qu'elles ont nouée ensemble, ainsi que l'expertise du Dre Bouchard sur la maladie et la manière dont les patients peuvent mener une vie épanouie tout en gérant les symptômes et les traitements.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Betinna Hamelin, President & CEO of Innovative Medicines Canada (IMC) - the national association representing the voice of Canada’s innovative pharmaceutical industry. They talk about what IMC does, the role of pharma in drug development and access, opportunities for collaboration between patients, clinicians, and industry, and the drug approval process in Canada. Learn more about Innovative Medicines Canada at https://innovativemedicines.ca/

In this episode, Dr. Paul Wheatley-Price chats with Dr. Arielle Elkrief, Medical Oncologist, Co-Director of the CHUM Microbiome Center, and Clinician-Scientist at the University of Montreal. They discuss everything about the microbiome and gut health - what is the microbiome, why it's important in cancer and treatments, tips for a healthy microbiome, antibiotics, and even "poop pills".

In this episode, Dr. Paul Wheatley-Price is back for another update into all the newest highlights from recent clinical trials for EGFR-positive lung cancer treatments. Dr. Stephen Liu is the Director of Thoracic Oncology and Professor of Medicine at Georgetown University in Washington, DC, and he co-hosts his own podcast with the IASLC, "Lung Cancer Considered". They are also joined by Emi Bossio, a passionate patient advocate who lives with EGFR+ lung cancer and has a number of roles, including as a member on LCC's Board of Directors.

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Andrew Robinson and Dr. Nathalie Daaboul on all the highlights coming out of this year's 2025 ASCO Conference, held in Chicago back in June. They discuss major developments in treatment for small cell lung cancer (SCLC), updates in immunotherapy, and a couple of unique drugs coming down the pipeline. Dr. Robinson is a Medical Oncologist and Associate Professor at Queen's University in Kingston, ON. Dr. Daaboul is a Medical Oncologist at L'Hôpital Charles Lemoyne in Montreal, Associate Professor at the University of Sherbrooke, and also the host of the Lung Cancer Voices podcast series in French!

In this episode, Dr. Paul Wheatley-Price chats with Dr. Adrian Sacher on everything there is to know about KRAS lung cancer. What is KRAS lung cancer, how is it tested, and what it means in terms of treatment options for those who have this subtype of lung cancer. Dr. Adrian Sacher is a Thoracic Medical Oncologist at the Princess Margaret Cancer Centre and Assistant Professor in the Departments of Medicine & Immunology at the University of Toronto.

In our special 100th episode, Dr. Paul Wheatley-Price reunites with the Current and Past Presidents of Lung Cancer Canada, to take a trip down memory lane on how lung cancer (and LCC) has evolved over the decades, what's happening now, and what's to come in the future! Dr. Paul Wheatley-Price is joined by our new President Dr. Rosalyn Juergens, and Past Presidents Dr. Stephanie Snow and Dr. Natasha Leighl. Watch the full video recording at https://youtu.be/tFfVVQvvf0s

In this episode, Dr. Paul Wheatley-Price chats with Claire Hopkins, Registered Dietician at the Princess Margaret Cancer Center, about all things nutrition and maintaining heathy eating habits for lung cancer patients. What exactly is the role of a dietician vs nutritionist, is sugar really bad for cancer, tips to maintain a healthy appetite, reasons behind weight loss during treatment, and the best supplements or meal alternatives.

Dans cet épisode, la Dre Nathalie Daaboul discute du processus d'investigation et de diagnostic du cancer du poumon avec la Dre Nicole Bouchard. La Dre Bouchard est pneumologue spécialisée en oncologie pulmonaire à l'Université de Sherbrooke et siège au comité consultatif médical de Cancer pulmonaire Canada.

In this episode, Dr. Paul Wheatley-Price and Dr. Renelle Myers discuss all there is to know about lung cancer screening in 2025 - what is lung cancer screening and why is it important, who can get screened, where it's available, and the latest technologies and advances in screening. Dr. Myers is an Interventional Pulmonologist and Clinician-Scientist at BC Cancer, and Clinical Associate Professor at the University of British Columbia.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Dugald Seely, ND on naturopathic medicine and lung cancer - what is naturopathy vs alternative vs homeopathic medicine, how it can play a role within lung cancer care, the innovative research he's been doing, and busting some of the myths about CAM. Dr. Seely is a Naturopathic Doctor in Ottawa, CEO of the Center for Health Innovation, and Executive Director at the Patterson Institute for Integrative Oncology Research at the Canadian College of Naturopathic Medicine.

In this episode, Dr. Paul Wheatley-Price chats with Laura Floyd, a lung cancer advocate and comedian in BC to share her experience as a lung cancer patient, the importance of communication between patients and physicians, and even cracking a few jokes along the way!

In a special episode of Lung Cancer Voices, Dr. Paul Wheatley-Price sits down with Laura Greer, Senior VP & National Lead, Health & Wellness at Hill+Knowlton, for a timely discussion on what political change — or uncertainty — could mean for health policy, research funding, and advocacy? They chat about how the shifting political landscapes may impact healthcare: ripple effects of tariffs and economic pressures on patient care, cuts to NIH/HHS in the U.S. and what they mean for Canadian research, and how charities like Lung Cancer Canada can keep advocating — no matter the political climate.

In this episode, Dr. Paul Wheatley-Price sits down with Bev Moir, who's been living with stage 4 EGFR+ lung cancer since 2019, and her husband Ron Foreman. Bev and Ron share their experiences navigating this tough diagnosis, the important role that Ron plays as a caregiver supporting Bev throughout the journey, and what made Bev decide to use her voice as a platform and advocate for those living with lung cancer.

In this episode, Dr. Paul Wheatley-Price sits down with Amy Coupal, CEO of The Ontario Caregiver Organization (OCO) to talk about the current statistics and challanges that caregivers face, tips for balancing self-care, and how the OCO can support those caring for loved ones in Ontario and beyond. For information and support for caregivers, call the Ontario Caregiver Helpline at 1-833-416-2273 (available 24/7), or visit www.ontariocaregiver.ca

In this episode, Dr. Paul Wheatley-Price sits down with Christine Fader to share her husband Michael's experience being diagnosed with two cancers in his lifetime - throat cancer in 2018, then large cell lung cancer in 2020. Christine shares some of the difficult treatment experiences that Michael went through, the growing importance of trauma-informed care, navigating grief, and some tips for fellow caregivers around asking for support during tough times. Learn more about Christine's work and Michael's story at https://christinefader.com/about/